Thiel Capital

Total investments

36

Average round size

26M

Portfolio companies

24

Rounds per year

2.77

Lead investments

5

Follow on index

0.31

Exits

1

Stages of investment
Venture
Areas of investment
BiotechnologySoftwareFinancial ServicesHealth CareManufacturingMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Summary

The company was established in North America in United States. The main office of represented VC is situated in the Los Angeles.

The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2018.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Thiel Capital, startups are often financed by R Ventures, Venture University, VU Venture Partners. The meaningful sponsors for the fund in investment in the same round are R Ventures, Bonit Capital, Y Combinator. In the next rounds fund is usually obtained by Shougang Fund, Sherpa Venture Capital, R Ventures.

The current fund was established by Peter Thiel. The overall number of key employees were 5.

The fund has exact preference in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Compass Therapeutics, 3T Biosciences, Spark Neuro. Among the most popular fund investment industries, there are Therapeutics, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

Show more

Investments analytics

Analytics

Total investments
36
Lead investments
5
Exits
1
Rounds per year
2.77
Follow on index
0.31
Investments by industry
  • Biotechnology (15)
  • Health Care (14)
  • Therapeutics (11)
  • Life Science (8)
  • Software (5)
  • Show 42 more
Investments by region
  • Germany (6)
  • Cayman Islands (1)
  • United States (22)
  • China (1)
  • Singapore (2)
Peak activity year
2020
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
5
Avg. valuation at time of investment
106M
Group Appearance index
0.94
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Ready 24 Aug 2020 Software, Financial Services, FinTech Seed 1M United States, California, San Francisco
Rollup 20 May 2024 Seed 5M United States, California, West Hollywood

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.